These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11300866)

  • 1. A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.
    Robl JA; Sulsky R; Sun CQ; Simpkins LM; Wang T; Dickson JK; Chen Y; Magnin DR; Taunk P; Slusarchyk WA; Biller SA; Lan SJ; Connolly F; Kunselman LK; Sabrah T; Jamil H; Gordon D; Harrity TW; Wetterau JR
    J Med Chem; 2001 Mar; 44(6):851-6. PubMed ID: 11300866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.
    Chandler CE; Wilder DE; Pettini JL; Savoy YE; Petras SF; Chang G; Vincent J; Harwood HJ
    J Lipid Res; 2003 Oct; 44(10):1887-901. PubMed ID: 12837854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents.
    Magnin DR; Biller SA; Wetterau J; Robl JA; Dickson JK; Taunk P; Harrity TW; Lawrence RM; Sun CQ; Wang T; Logan J; Fryszman O; Connolly F; Jolibois K; Kunselman L
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1337-40. PubMed ID: 12657277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits.
    Wetterau JR; Gregg RE; Harrity TW; Arbeeny C; Cap M; Connolly F; Chu CH; George RJ; Gordon DA; Jamil H; Jolibois KG; Kunselman LK; Lan SJ; Maccagnan TJ; Ricci B; Yan M; Young D; Chen Y; Fryszman OM; Logan JV; Musial CL; Poss MA; Robl JA; Simpkins LM; Slusarchyk WA; Sulsky R; Taunk P; Magnin DR; Tino JA; Lawrence RM; Dickson JK; Biller SA
    Science; 1998 Oct; 282(5389):751-4. PubMed ID: 9784135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
    Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
    J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaminoindanes as microsomal triglyceride transfer protein inhibitors.
    Ksander GM; deJesus R; Yuan A; Fink C; Moskal M; Carlson E; Kukkola P; Bilci N; Wallace E; Neubert A; Feldman D; Mogelesky T; Poirier K; Jeune M; Steele R; Wasvery J; Stephan Z; Cahill E; Webb R; Navarrete A; Lee W; Gibson J; Alexander N; Sharif H; Hospattankar A
    J Med Chem; 2001 Dec; 44(26):4677-87. PubMed ID: 11741485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
    Chrysselis MC; Rekka EA; Kourounakis PN
    J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells.
    Jamil H; Gordon DA; Eustice DC; Brooks CM; Dickson JK; Chen Y; Ricci B; Chu CH; Harrity TW; Ciosek CP; Biller SA; Gregg RE; Wetterau JR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11991-5. PubMed ID: 8876250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal triglyceride transfer protein inhibition: a novel treatment for lowering plasma cholesterol.
    Das G; Rees A
    Curr Opin Lipidol; 2014 Dec; 25(6):471-3. PubMed ID: 25370457
    [No Abstract]   [Full Text] [Related]  

  • 12. Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
    Funatsu T; Kakuta H; Takasu T; Miyata K
    Eur J Pharmacol; 2002 Nov; 455(2-3):161-7. PubMed ID: 12445582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal triacylglycerol transfer protein prevents presecretory degradation of apolipoprotein B-100. A dithiothreitol-sensitive protease is involved.
    Benoist F; Nicodeme E; Grand-Perret T
    Eur J Biochem; 1996 Sep; 240(3):713-20. PubMed ID: 8856075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Novel Benzimidazole-2-carboxamide Derivatives and in Vivo Antihyperlipidemic Activity Evaluation.
    Sheikha GA; Bkhaitan MM; Kalloush H; Hamadneh L; Khalaf RA; Al-Qirim T; Al-Hiari Y
    Chem Pharm Bull (Tokyo); 2018; 66(4):423-426. PubMed ID: 29607907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats.
    Dhote V; Joharapurkar A; Kshirsagar S; Dhanesha N; Patel V; Patel A; Raval S; Jain M
    Clin Exp Pharmacol Physiol; 2011 May; 38(5):338-44. PubMed ID: 21401695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B binding to microsomal triglyceride transfer protein decreases with increases in length and lipidation: implications in lipoprotein biosynthesis.
    Hussain MM; Bakillah A; Jamil H
    Biochemistry; 1997 Oct; 36(42):13060-7. PubMed ID: 9335568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide releasing morpholine derivatives as hypolipidemic and antioxidant agents.
    Chrysselis MC; Rekka EA; Siskou IC; Kourounakis PN
    J Med Chem; 2002 Nov; 45(24):5406-9. PubMed ID: 12431068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.
    Sashidhara KV; Kumar A; Kumar M; Srivastava A; Puri A
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6504-7. PubMed ID: 20932744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly.
    Gordon DA; Jamil H
    Biochim Biophys Acta; 2000 Jun; 1486(1):72-83. PubMed ID: 10856714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.